Publications by authors named "B Hernandez-Machin"
Background And Objectives: Bexarotene has been approved to treat advanced stage cutaneous T-cell lymphomas (CTCL) since 1999. However, very few data have been published on its long-term safety and efficacy profile. The aim of this study is to determine the tolerability to bexarotene and outcomes by collecting the 2nd largest case series to date on its long-term use vs CTCL.
View Article and Find Full Text PDFBackground: Reliable prognostic factors for patients with primary cutaneous anaplastic large cell lymphoma (PCALCL) are lacking.
Objective: To identify prognostic factors for specific survival in patients with PCALCL.
Methods: Using the convenience sampling method, patients with PCALCL diagnosed from May 1986 to August 2017 in 16 University Departments were retrospectively reviewed.
Background: Data regarding response to treatment in lymphomatoid papulosis (LyP) are scarce.
Aim: To assess the daily clinical practice approach to LyP and the response to first-line treatments.
Methods: This was a retrospective study enrolling 252 patients with LyP.
Background: Patch or plaque stages in mycosis fungoides (MF) have different prognoses. The recent staging system proposed for MF discriminates between patches and plaques based upon clinical features.
Objective: To estimate interdermatologist agreement on the morphological evaluation of MF lesions.
Background: Mycosis fungoides (MF) is the most common form of primary cutaneous T cell lymphoma. Psoralen combined with ultraviolet A (PUVA) is a first-line treatment for early-stage disease.
Objectives: This study was conducted to assess the clinical effectiveness of and tolerance to PUVA monotherapy in MF.